Treating systolic hypertension in the very elderly with valsartan-hydrochlorothiazide vs. either monotherapy: ValVET primary results.

MLA

Izzo, Joseph L., Jr, et al. “Treating Systolic Hypertension in the Very Elderly with Valsartan-Hydrochlorothiazide vs. Either Monotherapy: ValVET Primary Results.” Journal of Clinical Hypertension (Greenwich, Conn.), vol. 13, no. 10, Oct. 2011, pp. 722–30. EBSCOhost, https://doi.org/10.1111/j.1751-7176.2011.00498.x.

APA

Izzo, J. L., Jr, Weintraub, H. S., Duprez, D. A., Purkayastha, D., Zappe, D., Samuel, R., & Cushman, W. C. (2011). Treating systolic hypertension in the very elderly with valsartan-hydrochlorothiazide vs. either monotherapy: ValVET primary results. Journal of Clinical Hypertension (Greenwich, Conn.), 13(10), 722–730. https://doi.org/10.1111/j.1751-7176.2011.00498.x

Chicago

Izzo, Joseph L, Jr, Howard S Weintraub, Daniel A Duprez, Das Purkayastha, Dion Zappe, Rita Samuel, and William C Cushman. 2011. “Treating Systolic Hypertension in the Very Elderly with Valsartan-Hydrochlorothiazide vs. Either Monotherapy: ValVET Primary Results.” Journal of Clinical Hypertension (Greenwich, Conn.) 13 (10): 722–30. doi:10.1111/j.1751-7176.2011.00498.x.